Cellyan Biotechnology HKPD
NASDAQ HKPD
$0.11 0.00 (-1.78%)
As of: Oct 20, 2026 · 11:37 AM EDT

Cellyan Biotechnology (HKPD) Current Deferred Revenue (2024 - 2026)

Updated

Cellyan Biotechnology's Current Deferred Revenue came in at $127,464 for the quarter ended Mar 31, 2026, up 2.4% from $124,507 a year earlier.

Analysis

Cellyan Biotechnology (HKPD) Current Deferred Revenue (2024 - 2026) Analysis & Trends

Going back to the quarter ended Mar 31, 2024, Cellyan Biotechnology's Current Deferred Revenue data covers 5 quarters.

  • Going back by year, Current Deferred Revenue was $124,507 in the year ended Mar 31, 2025 (-34.8%) and $191,066 in the year ended Mar 31, 2024.
  • The five-year range for quarterly Current Deferred Revenue is $74,877 (the quarter ended Sep 30, 2024) to $529,008 (the quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Union Pacific 170.68 Bn 165.21 Bn -
2 Csx 89.35 Bn 85.55 Bn -
3 United Parcel Service 84.30 Bn 61.20 Bn -
4 Canadian Pacific Kansas City 77.55 Bn 76.57 Bn -
5 Norfolk Southern 73.08 Bn 67.72 Bn -
6 Fedex 71.32 Bn 37.26 Bn -
7 Delta Air Lines 50.26 Bn 32.45 Bn -
8 Old Dominion Freight Line 39.26 Bn 38.52 Bn -
9 United Airlines Holdings 31.96 Bn -24.41 Bn -
10 Cellyan Biotechnology 1.80 Mn 1.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 127,464.00
Sep 30, 2025 529,008.00
Mar 31, 2025 124,507.00
Sep 30, 2024 74,877.00
Mar 31, 2024 191,066.00
API Access

Cellyan Biotechnology Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HKPD&period=max&api_key=YOUR_API_KEY